Cargando…

Latent trait modeling of tau neuropathology in progressive supranuclear palsy

Progressive supranuclear palsy (PSP) is the second most common neurodegenerative Parkinsonian disorder after Parkinson’s disease, and is characterized as a primary tauopathy. Leveraging the considerable clinical and neuropathologic heterogeneity associated with PSP, we measured tau neuropathology as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouri, Naomi, Murray, Melissa E., Reddy, Joseph S., Serie, Daniel J., Soto-Beasley, Alexandra, Allen, Mariet, Carrasquillo, Minerva M., Wang, Xue, Castanedes, Monica Casey, Baker, Matthew C., Rademakers, Rosa, Uitti, Ryan J., Graff-Radford, Neill R., Wszolek, Zbigniew K., Schellenberg, Gerard D., Crook, Julia E., Ertekin-Taner, Nilüfer, Ross, Owen A., Dickson, Dennis W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043857/ https://www.ncbi.nlm.nih.gov/pubmed/33635380 http://dx.doi.org/10.1007/s00401-021-02289-0

Ejemplares similares

Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
por: Sakae, Nobutaka, et al.
Publicado: (2019)

Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
por: Strickland, Samantha L., et al.
Publicado: (2020)

Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
por: Allen, Mariet, et al.
Publicado: (2018)

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
por: Valentino, Rebecca R., et al.
Publicado: (2020)

Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci
por: Sanchez-Contreras, Monica Y., et al.
Publicado: (2018)

Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions
por: Wang, Xue, et al.
Publicado: (2022)

Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
por: Min, Yuhao, et al.
Publicado: (2023)

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)

Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study
por: Potts, Lisa F, et al.
Publicado: (2012)

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2015)

Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
por: Roemer, Shanu F., et al.
Publicado: (2022)

Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease
por: Hanna Al-Shaikh, Fadi S., et al.
Publicado: (2019)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures
por: Valentino, Rebecca R., et al.
Publicado: (2022)

African American exome sequencing identifies potential risk variants at Alzheimer disease loci
por: N'Songo, Aurelie, et al.
Publicado: (2017)

ABCA7 loss-of-function variants, expression, and neurologic disease risk
por: Allen, Mariet, et al.
Publicado: (2017)

Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes
por: Boon, Baayla D.C., et al.
Publicado: (2023)

Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old
por: Lachner, Christian, et al.
Publicado: (2022)

Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy
por: Höglinger, Günter U., et al.
Publicado: (2011)

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2023)

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
por: Ma, Li, et al.
Publicado: (2016)

Evaluation of the Role of SNCA Variants in Survival without Neurological Disease
por: Heckman, Michael G., et al.
Publicado: (2012)

LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)
por: Lincoln, Sarah, et al.
Publicado: (2013)

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
por: Smith, Ruben, et al.
Publicado: (2016)

Plasma Biomarkers of Alzheimer’s Disease in African Americans
por: Deniz, Kaancan, et al.
Publicado: (2021)

Late-onset Alzheimer disease risk variants mark brain regulatory loci
por: Allen, Mariet, et al.
Publicado: (2015)

Fragile X-associated tremor ataxia syndrome with co-occurrent progressive supranuclear palsy-like neuropathology
por: Sacino, Amanda N., et al.
Publicado: (2019)

MAPT ‐Associated Familial Progressive Supranuclear Palsy with Typical Corticobasal Degeneration Neuropathology: A Clinicopathological Report
por: Cullinane, Patrick W., et al.
Publicado: (2023)

Gene-Environment Interactions in Progressive Supranuclear Palsy
por: Litvan, Irene, et al.
Publicado: (2021)

Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease
por: Chung, Jaeyoon, et al.
Publicado: (2018)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans
por: Reddy, Joseph S., et al.
Publicado: (2022)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Genetics of Progressive Supranuclear Palsy
por: Im, Sun Young, et al.
Publicado: (2015)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Comparative evaluation for the globin gene depletion methods for mRNA sequencing using the whole blood-derived total RNAs
por: Jang, Jin Sung, et al.
Publicado: (2020)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_md6ij8puc8923ac7nqhmih0iji